심장내과
최재웅 교수
- [전문분야]
- 심혈관 중재 시술
- [전문진료]
- 관상동맥, 대동맥, 말초 혈관 중재 시술
포기하면 핑계를 찾고, 하려 하면 방법을 찾는다.
심근증, 관상동맥, 심부전, 대동맥혈관 질환으로 고통을 받고 있는 환자들이 건강하고 행복한 삶이 될 수 있도록 항상 노력하고 있습니다. 또한 환자 한분 한분을 모두를 가족이 대하고 최상의 치료를 받을 수 있도록 노력하겠습니다. 감사합니다.
논문
- Routine Functional Testing or Standard Care in High-Risk Patients after PCI:August 27, 2022
N Engl J Med 2022;387:905-915
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial: Lancet. Volume 391, Issue 10127p1274-1284March 31, 2018
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial: Eur Heart J. 2026 May 5;47(17):2044-2055.
Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR): J Interv Cardiol
. 2021 Jul 20:2021:6698582
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial: Am Heart J. 2023 May:259:58-67.
Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease: J Am Coll Cardiol. 2024 Mar 5;83(9):890-900
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CH EuroIntervention. 2024 Nov 4;20(21):e1355-e1362.
Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: the comparison of efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial: Am Heart J. 2013 May;165(5):733-43.
